BODYCOMP
LIVE

Serial Number

98230925

Owner

ImpediMed Limited

Attorney

Christina M. Licursi

Filing Date

Oct 19, 2023

Add to watchlist:

No watchlists yet
View on USPTO

BODYCOMP Trademark

Serial Number: 98230925

BODYCOMP is a trademark filed by ImpediMed Limited on October 19, 2023. The trademark is classified under Class 9 (Computers & Electronics), Class 10 (Medical Apparatus), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently pending registration.

Owner Contact Info

ImpediMed Limited (14 trademarks)

Unit 1, 50 Parker Court
Pinkenba, Queensland 4008 , AU

Entity Type: 11

Trademark Details

Filing Date

October 19, 2023

Registration Date

Not Registered

Goods & Services

(Based on 44(d) Priority Application) (Based on Use in Commerce) (Based on Intent To Use) Providing medical information in the field of human body composition, in particular measuring human body mass and composition; providing an online website portal featuring medical information in the field of bioimpedance; medical analysis services for diagnostic and treatment purposes provided by medical laboratories

(Based on 44(d) Priority Application) (Based on Use in Commerce) (Based on Intent To Use) Providing temporary use of online, non-downloadable software for bioimpedance analysis, namely, fluid, tissue, metabolic, muscle, and fat analysis for medical purposes

(Based on 44(d) Priority Application) (Based on Use in Commerce) (Based on Intent To Use) Downloadable computer and mobile application software for bioimpedance analysis, namely, fluid, tissue, metabolic, muscle, and fat analysis for medical purposes; software as a medical device (SaMD), downloadable, for analyzing data related to fluids, tissues, the metabolism, muscles, and fat

(Based on 44(e)) (Based on Intent To Use) Multifrequency bioimpedance analysers being fluid, tissue, metabolic, muscle, and fat analyzers for medical purposes

Filing History

NOTIFICATION OF NON-FINAL ACTION E-MAILED
Dec 23, 2025 GNRN
NON-FINAL ACTION E-MAILED
Dec 23, 2025 GNRT
NON-FINAL ACTION WRITTEN
Dec 23, 2025 CNRT
TEAS/EMAIL CORRESPONDENCE ENTERED
Dec 17, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 17, 2025 CRFA
ASSIGNED TO LIE
Dec 1, 2025 ALIE
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Nov 14, 2025 ERSI
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Aug 21, 2025 XELG
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Aug 21, 2025 XELR
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
May 21, 2025 GNS2
INQUIRY TO SUSPENSION E-MAILED
May 21, 2025 GNSI
SUSPENSION INQUIRY WRITTEN
May 21, 2025 CNSI
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Nov 20, 2024 GNS3
LETTER OF SUSPENSION E-MAILED
Nov 20, 2024 GNSL
SUSPENSION LETTER WRITTEN
Nov 20, 2024 CNSL
ASSIGNED TO EXAMINER
Oct 21, 2024 DOCK
TEAS/EMAIL CORRESPONDENCE ENTERED
Oct 9, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 9, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Oct 9, 2024 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jul 9, 2024 GNRN
NON-FINAL ACTION E-MAILED
Jul 9, 2024 GNRT
NON-FINAL ACTION WRITTEN
Jul 9, 2024 CNRT
ASSIGNED TO EXAMINER
Jun 4, 2024 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Oct 25, 2023 NWOS
NEW APPLICATION ENTERED
Oct 23, 2023 NWAP